Mayer Brown has hired Edwin Nazario as a partner in its Capital Markets practice in Washington, DC, the firm announced on October 28, 2026. Nazario focuses on commodities trading, derivatives transactions, and Dodd-Frank compliance. His clients include energy, agricultural, and petrochemical companies, commodity trading firms, investment banks, advisers, and funds. He is active in several International Swaps and Derivatives Association working groups. His arrival follows that of partner Danielle Abada, who joined from the Commodity Futures Trading Commission (CFTC). Mayer Brown has won "Americas Law Firm of the Year (Overall)" at GlobalCapital's Americas Derivatives Awards for five consecutive years, most recently in 2026.

Mayer Brown expands Life Sciences capabilities with FDA partners Scott Liebman and Dominick DiSabatino. Related People: Scott Liebman appointed co-leader of Life Sciences and leader of FDA Regulatory and Enforcement practice NEW YORK and WASHINGTON DC - Mayer Brown announced today that Scott Liebman and Dominick DiSabatino have joined the firm as partners in its Life Sciences practice. Both join from Sheppard, Mullin, Richter & Hampton LLP, where Scott was co-leader of the Life Sciences practice and leader of the FDA practice. They specialize in FDA rules and regulations and further strengthen Mayer Brown's capabilities advising pharmaceutical, biotechnology, medical device, healthcare, and digital health companies on complex regulatory, transactional, compliance, and enforcement matters. Scott will be based in New York and Washington DC, while Dominick will be in Washington DC. The additions reflect Mayer Brown's continued investment in the life sciences sector, where rapid scientific innovation, evolving regulatory requirements, acceleration in deal velocity, and increased government scrutiny continue to drive demand for sophisticated legal counsel. "Scott and Dominick are exceptional lawyers whose practices align with growing client needs across the life sciences industry," said Michael Olsen, co-leader of Mayer Brown's Litigation & Dispute Resolution practice. "Their expertise enhances our ability to advise clients on the complex regulatory, compliance, transactional, and enforcement issues they face and further strengthens our multidisciplinary life sciences platform." Scott joins Mayer Brown as co-leader of the firm's Life Sciences practice and leader of its FDA Regulatory and Enforcement practice. He brings decades of experience advising life sciences companies on FDA regulatory matters, compliance, enforcement, product development, investigations, transactions, M&A, in/out licensing, and other strategic business initiatives. Dominick advises life sciences companies on a broad range of matters, including complex FDA regulatory issues, R&D and commercial strategy and contracting, product launch readiness, internal and governmental investigations, corporate transactions, and enterprise-level healthcare compliance programs. "The life sciences industry is facing increasingly complex and rapidly changing regulatory, compliance, and enforcement challenges that require practical, business-focused advice," said Scott. "Mayer Brown's depth across litigation, investigations, regulatory counseling, and transactions creates a compelling platform for helping clients navigate those challenges. Dom and I are excited to join the firm and continue building its Life Sciences practice." "Scott and Dominick bring a leading life sciences practice to Mayer Brown, adding a significant new capability to our platform," said Allison Aviki, managing partner of Mayer Brown's New York Office. "They are highly regarded advisors whose experience and relationships will be an immediate asset to our clients. Their addition further expands our presence in the life sciences industry at a time of significant innovation and growth."

Former CFTC Senior Counsel Danielle Abada joins Mayer Brown. * Author Cynthia Lydia Marbaniang * Published October 13, 2026 NEW YORK - Mayer Brown today announced that Danielle Abada has joined the firm's Capital Markets practice as a partner in the New York office. She joins the firm from the U.S. Commodity Futures Trading Commission (CFTC), where she served as Senior Special Counsel in the Market Participants Division and previously served as Senior Counsel to CFTC Commissioner Kristin N. Johnson. "We're pleased to welcome Danielle to our firm," said firm Chair Jon Van Gorp. "Her experience at the CFTC will benefit clients as they navigate a rapidly evolving derivatives and digital assets regulatory environment that has seen significant innovation and market growth." At the CFTC, Danielle advised on complex legal, regulatory, and policy matters affecting CFTC-regulated entities and advanced the Commission's priorities on regulatory and market developments, including crypto assets and blockchain technologies, prediction markets and event contracts, and artificial intelligence. Prior to her government service, in private practice, Danielle represented financial institutions and fintechs on a broad range of regulatory, compliance, transactional, and legislative matters. She also advised clients on the use of emerging and evolving technologies, including distributed ledgers, digital assets, and artificial intelligence. Danielle has represented banks, swap dealers, broker-dealers, exchanges, asset and investment managers, hedge funds and proprietary trading firms in a range of banking, derivatives and securities regulatory and transactional matters. Danielle joins lawyers in the firm's preeminent Derivatives & Structured Products and Fintech practices. Mayer Brown has been named "Americas Law Firm of the Year (Overall)" at GlobalCapital's Americas Derivatives Awards for five consecutive years, including most recently in 2026. The firm is ranked in Tier 1 by Chambers USA, IFLR1000 and The Legal 500 US in various derivatives and structured products categories. The firm is also ranked in Tier 1 by The Legal 500 US for Fintech and ranked as a leading firm by Chambers FinTech in five FinTech Legal categories for the United States, including Corporate, Securities, and Financing. Where the legal industry reads first. No spam. Unsubscribe anytime. From Legal Desire Is your firm the one being cited, or the one being skipped? Legal Desire ran the test. On several everyday legal questions, software companies are answering and law firms are not. Legal Desire help firms fix that, and Legal Desire build the technology behind the practice. Lawyers and firms: get featured on Legal Desire. Share your deals, lateral moves, firm news and insights with 1M+ monthly readers: founders, law firm partners, general counsel and practising lawyers across the US, UK, EU and GCC.